197 related articles for article (PubMed ID: 36125989)
1. Self-reported cognitive impairments and quality of life in patients with gastrointestinal stromal tumor: Results of a multinational survey.
Ferguson RJ; Manculich J; Chang H; Sareen NJ; Snitz BE; Terhorst L; Bovbjerg DH; Duensing AU
Cancer; 2022 Nov; 128(22):4017-4026. PubMed ID: 36125989
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, Impact, and Correlates of Severe Fatigue in Patients With Gastrointestinal Stromal Tumors.
Poort H; van der Graaf WT; Tielen R; Vlenterie M; Custers JA; Prins JB; Verhagen CA; Gielissen MF; Knoop H
J Pain Symptom Manage; 2016 Aug; 52(2):265-71. PubMed ID: 27233141
[TBL] [Abstract][Full Text] [Related]
3. Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?
Custers JA; Tielen R; Prins JB; de Wilt JH; Gielissen MF; van der Graaf WT
Acta Oncol; 2015; 54(8):1202-8. PubMed ID: 25734906
[TBL] [Abstract][Full Text] [Related]
4. Caregivers of patients receiving long-term treatment with a tyrosine kinase inhibitor (TKI) for gastrointestinal stromal tumour (GIST): a cross-sectional assessment of their distress and burden.
Langenberg SMCH; Reyners AKL; Wymenga ANM; Sieling GCM; Veldhoven CMM; van Herpen CML; Prins JB; van der Graaf WTA
Acta Oncol; 2019 Feb; 58(2):191-199. PubMed ID: 30280630
[TBL] [Abstract][Full Text] [Related]
5. Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data.
den Hollander D; Dirkson AR; Verberne S; Kraaij W; van Oortmerssen G; Gelderblom H; Oosten A; Reyners AKL; Steeghs N; van der Graaf WTA; Desar IME; Husson O
Support Care Cancer; 2022 Jun; 30(6):5137-5146. PubMed ID: 35233640
[TBL] [Abstract][Full Text] [Related]
6. Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists.
van de Wal D; Fauske L; Bruland ØS; Jones RL; Kasper B; Wilson R; van der Graaf WTA; Husson O
Support Care Cancer; 2023 May; 31(6):352. PubMed ID: 37233829
[TBL] [Abstract][Full Text] [Related]
7. Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study.
van de Wal D; den Hollander D; Desar IME; Gelderblom H; Oosten AW; Reyners AKL; Steeghs N; Husson O; van der Graaf WTA
Support Care Cancer; 2024 Apr; 32(5):279. PubMed ID: 38594390
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
[TBL] [Abstract][Full Text] [Related]
9. Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors.
van Elst JM; IJzerman NS; Mathijssen RHJ; Steeghs N; Reyners AKL; de Haan JJ
Support Care Cancer; 2022 Mar; 30(3):2307-2315. PubMed ID: 34727226
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of GIST patients with and without current tyrosine kinase inhibitor treatment: Cross-sectional results of a German multicentre observational study (PROSa).
Eichler M; Pink D; Menge F; Jakob J; Hentschel L; Richter S; Hohenberger P; Kasper B; Andreou D; Singer S; Grützmann R; Dmytrow DI; Arndt K; Tuchscherer A; Reichardt P; Ahrens M; Kunitz A; Mohm J; Bornhäuser M; Schmitt J; Schuler MK
Eur J Cancer Care (Engl); 2021 Nov; 30(6):e13484. PubMed ID: 34342924
[TBL] [Abstract][Full Text] [Related]
11. Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Schöffski P; Mir O; Kasper B; Papai Z; Blay JY; Italiano A; Benson C; Kopeckova K; Ali N; Dileo P; LeCesne A; Menge F; Cousin S; Wardelmann E; Wozniak A; Marreaud S; Litiere S; Zaffaroni F; Nzokirantevye A; Vanden Bempt I; Gelderblom H
Eur J Cancer; 2020 Jul; 134():62-74. PubMed ID: 32470848
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal stromal tumors (GIST) related emergencies.
Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
[TBL] [Abstract][Full Text] [Related]
13. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
Hemming ML; Lawlor MA; Andersen JL; Hagan T; Chipashvili O; Scott TG; Raut CP; Sicinska E; Armstrong SA; Demetri GD; Bradner JE
Cancer Res; 2019 Mar; 79(5):994-1009. PubMed ID: 30630822
[TBL] [Abstract][Full Text] [Related]
14. The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.
Rutkowski P; Bylina E; Klimczak A; Switaj T; Falkowski S; Kroc J; Lugowska I; Brzeskwiniewicz M; Melerowicz W; Osuch C; Mierzejewska E; Wasielewski K; Woźniak A; Grzesiakowska U; Nowecki ZI; Siedlecki JA; Limon J
BMC Cancer; 2012 Mar; 12():107. PubMed ID: 22439647
[TBL] [Abstract][Full Text] [Related]
15. Surgical Management of Metastatic Gastrointestinal Stromal Tumors.
Yonkus JA; Alva-Ruiz R; Grotz TE
Curr Treat Options Oncol; 2021 Mar; 22(5):37. PubMed ID: 33743084
[TBL] [Abstract][Full Text] [Related]
16. A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor.
Rosenbaum E; Kelly C; D'Angelo SP; Dickson MA; Gounder M; Keohan ML; Movva S; Condy M; Adamson T; Mcfadyen CR; Antonescu CR; Hwang S; Singer S; Qin LX; Tap WD; Chi P
Oncologist; 2019 Oct; 24(10):1309-e983. PubMed ID: 31213500
[TBL] [Abstract][Full Text] [Related]
17. Predictors of quality of life among adults with self-reported cancer related cognitive impairment.
Maeir T; Nahum M; Makranz C; Tsabari S; Peretz T; Gilboa Y
Disabil Rehabil; 2023 Mar; 45(6):1056-1062. PubMed ID: 35297702
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST).
Rutkowski P; Bylina E; Lugowska I; Teterycz P; Klimczak A; Streb J; Czarnecka AM; Osuch C
J Geriatr Oncol; 2018 Sep; 9(5):520-525. PubMed ID: 29602734
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy-related Cognitive Impairment and Quality of Life in People with Colon Cancer: The Mediating Effect of Psychological Distress].
Oh PJ; Kim JH
J Korean Acad Nurs; 2016 Feb; 46(1):19-28. PubMed ID: 26963411
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib.
Reichardt P; Kang YK; Rutkowski P; Schuette J; Rosen LS; Seddon B; Yalcin S; Gelderblom H; Williams CC; Fumagalli E; Biasco G; Hurwitz HI; Kaiser PE; Fly K; Matczak E; Chen L; Lechuga MJ; Demetri GD
Cancer; 2015 May; 121(9):1405-13. PubMed ID: 25641662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
